Writing an article about market forces and issues facing the Pharmaceutical industry is easy. But Mark Halliday in his recent article “Success Factors for Market Access in the Pharmaceutical Industry” has put together a collection of ideas to to improve market access. Mark talks about the need to recognize the market has fragmented, and then… more »
Market Access is a Changing – Map Stakeholders to Understand Payor Policies
11/23/2010 By Leave a Comment
Vicious Cycle or Virtuous Cycle? Thought Leaders Debate the Value of Thought Leaders
09/20/2010 By Leave a Comment
Where should we draw the line between considering pharmaceutical key opinion leaders as thought leaders vs. calling them “influence peddlers”? A recent article published in “The Chronicle of Higher Education” casts aspersions on the entire protocol of co-mingling powerful KOLs, medical doctors and the academic research community within the context of drug development. We disagree…
Report from KOL Relationship Summit
08/26/2010 By Leave a Comment
![liberty_bell_1[1]](http://www.lnxresearch.com/blog/wp-content/uploads/2010/08/liberty_bell_11-90x90.jpg "liberty_bell_1[1]")
You couldn’t tell it was conference host eXL Pharma’s first year foray into a new subject area: KOL Relationship Summit. The dialogue amongst the audience and speakers was top notch – all too often, a conference is a series of talking heads, but that was not the case.
Top Researchers – Diabetes Type II
03/25/2010 By Leave a Comment
Who are the global researchers leading the pack in research for Diabetes Type II? It may not be the people you expected!
If companies were out of work, they’d probably learn to network
03/25/2010 By 1 Comment
Some pharmaceutical and biotech companies just don’t know how to network. It’s time they learn. Networking for our next job. It’s a familiar task for many of us. We reach out to our connections, both strong connections and our weak associations, creating if you will a radar dish. Our friends and associates listen on our… more »
88,000 people and still networking for Key Opinion Leaders the old fashioned way?
03/25/2010 By Leave a Comment
When the pharmaceutical research community is huge, how do you network effectively? How do you find the right people to tap into their expertise or leverage their social capital?